SCHEMBL7948067

SCHEMBL7948067

Cc1ccccc1P(N1CCCCC1)N1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.36
GAA P10253 3/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPT P10636 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
NPC1 O15118 1/20 0.36
MAPK1 P28482 1/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 1/20 0.36
TSHR P16473 2/20 0.36
ACHE P22303 2/20 0.36
POLB P06746 1/20 0.36
CYP2C19 P33261 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
HTT P42858 2/20 0.35
CYP2D6 P10635 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7947121 0.98 TSHR (0.38) L3MBTL1GAAALDH1A1MAPTTDP1
SCHEMBL11571785 0.83 TSHR (0.36) L3MBTL1GAAALDH1A1MAPTTDP1
SCHEMBL11570019 0.80 CYP2A13 (0.47) L3MBTL1GAAALDH1A1MAPTTDP1
SCHEMBL31355198 0.72 KMT2A (0.32) ALDH1A1ATMTSHRCYP2C19CYP3A4
SCHEMBL6901641 0.71 KCNH2 (0.41) ALDH1A1TDP1NPSR1TSHRCYP2C19
SCHEMBL11679024 0.69 CYP3A4 (0.39) GAAALDH1A1TDP1TSHRCYP2C19
O-Xylene SCHEMBL289634 0.68 TSHR (0.77) ALDH1A1MAPTTDP1SMN1; SMN2NPC1
SCHEMBL10914158 0.67 TSHR (0.47) ALDH1A1MAPTTDP1TSHRACHE
SCHEMBL15660496 0.67 TSHR (0.36) SMN1; SMN2TSHRACHE
SCHEMBL29357701 0.66 TSHR (0.53) ALDH1A1MAPTTDP1TSHRACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8487136-B2 Method for producing norbornene derivative NIPPON OIL CORPORATION (JP) 2013-07-16 US disclosed
US-8487136-B2 Method for producing norbornene derivative NIPPON OIL CORPORATION (JP) 2013-07-16 US disclosed
US-20100197970-A1 METHOD FOR PRODUCING NORBORNENE DERIVATIVE NIPPON OIL CORPORATION (JP) 2010-08-05 US disclosed
US-20100197970-A1 METHOD FOR PRODUCING NORBORNENE DERIVATIVE NIPPON OIL CORPORATION (JP) 2010-08-05 US disclosed
WO-2001007449-A1 PHOSPHINE/PALLADIUM COMPLEX CATALYSTS FOR ARYLATION OF OLEFINS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2001-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197970-A1 METHOD FOR PRODUCING NORBORNENE DERIVATIVE NR0B2, IGF1R, CPNE4 L3MBTL1 297/4885GAA 4196/4885ALDH1A1 1191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.